These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31017915)
1. Restraint stress induced gut dysmotility is diminished by a milk oligosaccharide (2'-fucosyllactose) in vitro. Farhin S; Wong A; Delungahawatta T; Amin JY; Bienenstock J; Buck R; Kunze WA PLoS One; 2019; 14(4):e0215151. PubMed ID: 31017915 [TBL] [Abstract][Full Text] [Related]
2. Effects of West C; Stanisz AM; Wong A; Kunze WA World J Gastroenterol; 2016 Dec; 22(48):10532-10544. PubMed ID: 28082805 [TBL] [Abstract][Full Text] [Related]
3. Lactobacillus rhamnosus strain JB-1 reverses restraint stress-induced gut dysmotility. West C; Wu RY; Wong A; Stanisz AM; Yan R; Min KK; Pasyk M; McVey Neufeld KA; Karamat MI; Foster JA; Bienenstock J; Forsythe P; Kunze WA Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27381257 [TBL] [Abstract][Full Text] [Related]
4. Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model. Xiao L; Leusink-Muis T; Kettelarij N; van Ark I; Blijenberg B; Hesen NA; Stahl B; Overbeek SA; Garssen J; Folkerts G; Van't Land B Front Immunol; 2018; 9():452. PubMed ID: 29593719 [TBL] [Abstract][Full Text] [Related]
5. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL). Coulet M; Phothirath P; Allais L; Schilter B Regul Toxicol Pharmacol; 2014 Feb; 68(1):59-69. PubMed ID: 24262411 [TBL] [Abstract][Full Text] [Related]
6. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061 [TBL] [Abstract][Full Text] [Related]
7. Effects of Mao B; He Z; Chen Y; Stanton C; Ross RP; Zhao J; Chen W; Yang B Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558551 [TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of a novel α-L-fucosidase from Pedobacter sp. and its application in synthesis of 3'-fucosyllactose and 2'-fucosyllactose. Shi R; Ma J; Yan Q; Yang S; Fan Z; Jiang Z Appl Microbiol Biotechnol; 2020 Jul; 104(13):5813-5826. PubMed ID: 32388762 [TBL] [Abstract][Full Text] [Related]
9. 2'-Fucosyllactose Promotes Colonization of Liu X; Zhang B; Zhang Y; Li W; Yin J; Shi A; Wang J; Wang S J Agric Food Chem; 2024 Mar; 72(9):4765-4776. PubMed ID: 38393978 [No Abstract] [Full Text] [Related]
10. Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers. Berger PK; Plows JF; Jones RB; Alderete TL; Yonemitsu C; Poulsen M; Ryoo JH; Peterson BS; Bode L; Goran MI PLoS One; 2020; 15(2):e0228323. PubMed ID: 32049968 [TBL] [Abstract][Full Text] [Related]
11. The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation. Perdijk O; van Neerven RJJ; van den Brink E; Savelkoul HFJ; Brugman S PLoS One; 2018; 13(7):e0200356. PubMed ID: 29990329 [TBL] [Abstract][Full Text] [Related]
12. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome. Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092 [TBL] [Abstract][Full Text] [Related]
13. Engineering two species of yeast as cell factories for 2'-fucosyllactose. Hollands K; Baron CM; Gibson KJ; Kelly KJ; Krasley EA; Laffend LA; Lauchli RM; Maggio-Hall LA; Nelson MJ; Prasad JC; Ren Y; Rice BA; Rice GH; Rothman SC Metab Eng; 2019 Mar; 52():232-242. PubMed ID: 30557615 [TBL] [Abstract][Full Text] [Related]
14. Human milk oligosaccharide 2'-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and faecal proteome profiles in mice. Paone P; Latousakis D; Terrasi R; Vertommen D; Jian C; Borlandelli V; Suriano F; Johansson MEV; Puel A; Bouzin C; Delzenne NM; Salonen A; Juge N; Florea BI; Muccioli GG; Overkleeft H; Van Hul M; Cani PD Gut; 2024 Sep; 73(10):1632-1649. PubMed ID: 38740509 [TBL] [Abstract][Full Text] [Related]
15. Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants. Marriage BJ; Buck RH; Goehring KC; Oliver JS; Williams JA J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):649-58. PubMed ID: 26154029 [TBL] [Abstract][Full Text] [Related]
16. Short communication: Genotype-phenotype association analysis revealed different utilization ability of 2'-fucosyllactose in Bifidobacterium genus. He Z; Yang B; Liu X; Ross RP; Stanton C; Zhao J; Zhang H; Chen W J Dairy Sci; 2021 Feb; 104(2):1518-1523. PubMed ID: 33358168 [TBL] [Abstract][Full Text] [Related]
17. Butyrate interacts with the effects of 2'FL and 3FL to modulate Zuurveld M; Diks MAP; Kiliaan PCJ; Garssen J; Folkerts G; Van't Land B; Willemsen LEM Front Nutr; 2023; 10():1305833. PubMed ID: 38174112 [TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of a Novel α-L-Fucosidase from Zhang Z; Li Y; Wu M; Gao Z; Wu B; He B Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511315 [TBL] [Abstract][Full Text] [Related]